Exciting Partnership for iGii: Innovating Menopause Diagnostics
iGii has entered into a multi-million-pound partnership with Prymexa to create an innovative toolkit for detecting signs of perimenopause.
We are delighted to share the incredible work from our portfolio company iGii. The business has entered into a multi-million-pound partnership with Prymexa to create an innovative toolkit for detecting signs of perimenopause.
With 60% of women under 40 feeling ill informed about perimenopause or menopause, this partnership addresses the critical gap in women’s health and has the potential to make a real impact in improving healthcare access and supporting women’s health through better diagnostics.
Huge congratulations to the iGii team for their continued success, we look forward to hearing what comes next!
https://bit.ly/4hxBulL